Stock Markets April 21, 2026 11:30 AM

Copenhagen benchmark slips as healthcare, tech and finance drag markets down

OMX Copenhagen 20 falls 1.63% as more stocks decline than rise; oil climbs and gold retreats

By Derek Hwang
Copenhagen benchmark slips as healthcare, tech and finance drag markets down

Denmark's stock market closed lower on Tuesday with the OMX Copenhagen 20 falling 1.63% as losses in Healthcare, Technology and Financials weighed on the index. Decliners outnumbered advancers by a wide margin. Among individual names, Oersted, NKT Holding and Demant were the top performers, while Zealand Pharma, Novo Nordisk Class B and Genmab led declines. Commodities and currency moves included stronger crude and Brent oil, a pullback in June gold futures, a firmer USD/DKK and a slightly stronger U.S. Dollar Index Futures.

Key Points

  • OMX Copenhagen 20 closed down 1.63% with Healthcare, Technology and Financials leading losses.
  • Declining stocks outnumbered advancing ones 77 to 42, with 18 unchanged, signaling broad selling pressure.
  • Commodities and FX moves included stronger crude and Brent oil, a decline in June gold futures, and a firmer USD/DKK and U.S. Dollar Index Futures.

Stocks in Denmark closed lower on Tuesday as weakness concentrated in the Healthcare, Technology and Financials sectors pushed the market down. The OMX Copenhagen 20 ended the trading session down 1.63%.

The session saw more sell pressure than buying interest on the Copenhagen Stock Exchange. Declining issues outnumbered advancers by 77 to 42, while 18 stocks finished unchanged.

Among the index constituents, Oersted AS (CSE:ORSTED) was the top gainer, rising 3.55% or 5.55 points to finish at 161.85. NKT Holding (CSE:NKT) added 0.77% or 7.00 points to close at 920.00, and Demant A/S (CSE:DEMANT) advanced 0.64% or 1.40 points to 221.20 in late trade.

On the downside, Zealand Pharma A/S (CSE:ZELA) led losses with a drop of 4.90% or 15.50 points to end at 300.80. Novo Nordisk A/S Class B (CSE:NOVOb) declined 4.19% or 10.80 points to close at 247.10, and Genmab (CSE:GMAB) fell 2.42% or 43.00 points to 1,732.00.


Commodity markets showed contrasting moves during the session. Crude oil for June delivery rose 2.79% or 2.44 to settle at $89.86 a barrel. Brent oil for June delivery climbed 2.83% or 2.70 to $98.18 a barrel. By contrast, the June Gold Futures contract retreated 1.41% or 68.06 to trade at $4,760.74 a troy ounce.

Foreign exchange rates also moved: USD/DKK was up 0.37% to 6.36, while EUR/DKK was essentially unchanged, moving 0.02% to 7.47. The US Dollar Index Futures increased 0.27% to 98.17.

The market action reflected selling pressure concentrated in several sectors rather than an across-the-board retreat, as a handful of stocks managed gains while many names moved lower.

Below are the session highlights and market indicators that defined the close.

  • Benchmark movement: OMX Copenhagen 20 down 1.63% at the close.
  • Advance-decline breadth: 42 advancers, 77 decliners, 18 unchanged.
  • Top gainers: Oersted AS up 3.55% to 161.85; NKT Holding up 0.77% to 920.00; Demant A/S up 0.64% to 221.20.
  • Top losers: Zealand Pharma A/S down 4.90% to 300.80; Novo Nordisk A/S Class B down 4.19% to 247.10; Genmab down 2.42% to 1,732.00.
  • Commodities: June crude oil $89.86 per barrel (up 2.79%); June Brent $98.18 per barrel (up 2.83%); June Gold Futures $4,760.74 per troy ounce (down 1.41%).
  • Currencies and indexes: USD/DKK 6.36 (up 0.37%); EUR/DKK 7.47 (up 0.02%); US Dollar Index Futures 98.17 (up 0.27%).

Market participants remained focused on the intra-day moves across both equities and commodities, with the Copenhagen exchange posting a clear imbalance between losers and winners at the close.

Risks

  • Sector concentration of losses in Healthcare, Technology and Financials could magnify downside for those sectors.
  • Rising crude and Brent oil prices may influence cost structures for energy-sensitive sectors and broader market sentiment.
  • A stronger USD/DKK and higher U.S. Dollar Index Futures may affect exporters and companies with significant foreign currency exposure.

More from Stock Markets

Tesla Registrations Fall 24% in California as Hybrids Expand Market Share Apr 21, 2026 UK tribunal clears path for £2.1 billion lawsuit accusing Microsoft of inflated cloud licensing Apr 21, 2026 Sullivan & Cromwell Apologizes After AI-Generated Errors Appeared in Court Filing Apr 21, 2026 SoundHound to Buy LivePerson; Stock Drops After Deal Announcement Apr 21, 2026 Kpler owners initiate sale of large minority stake in move that could value firm near $5 billion Apr 21, 2026